IMPORTANCE Autism behavioral therapy is effective but expensive and difficult to access. While mobile technology-based therapy can alleviate wait-lists and scale for increasing demand, few clinical trials exist to support its use for autism spectrum disorder (ASD) care.
A utism spectrum disorder (ASD) prevalence has increased dramatically in the United States in the past few decades to 1 in 59 children. 1 While the symptoms of ASD vary widely, difficulty with socialization is a core deficit. 2 Children struggle to engage in joint attention, sustain eye contact, and recognize facial expressions. [2] [3] [4] [5] Experts recommend 20 hours per week of applied behavioral analysis (ABA) 2, 6 often incorporating naturalistic developmental behavioral interventions 7 with a behavioral therapist for at least 2 years. 2 Although these behavioral interventions are effective, they are costly (between $40 000 and $60 000 per child per year 8 ), and many children face challenges generalizing therapy to real-world contexts. 7 Furthermore, the increase in prevalence of ASD has outpaced availability of behavioral therapists, creating wait-lists of up to 18 months in the United States. 9 Learning aids based on novel ubiquitous technologies using machine learning can begin to address these problems by creating opportunities for therapy that are accessible outside of the clinician's office. Such tools may generalize to the natural environment where the social skills are used and act as a care bridge while children wait for standard therapy.
We designed a wearable social learning aid for children with ASD to encourage facial engagement and provide feedback to the child during social interactions at home. A computer vision system runs on Google Glass that is wirelessly connected to a smartphone app to provide the intervention to the child wearing the glasses. We confirmed the feasibility of fit and its augmented reality form factor in an in-laboratory feasibility study 10 and in a field test of home usage by children with ASD. 11, 12 These design studies supported the hypothesis that children aged 4 to 17 years can comfortably wear the glasses and process the video and audio cues provided through the smart glasses unit. Furthermore, the field test study suggested that three 20-minute play sessions per week for 6 weeks could improve social behavior, with a mean improvement of 7.4 points on the Social Responsiveness Scale, Second edition (SRS-II) (P < .01). Finally, these studies generated a consensus by the participating children on the name, Superpower Glass (SG).
In the present study, we tested the hypothesis that children with ASD randomized to use SG at home for 6 weeks along with their ongoing ABA therapy will achieve greater improvements in socialization compared with children of the same age range engaged in ABA therapy alone. Although studies have established the feasibility of using digital technology platforms to deliver therapy to children with ASD, 13, 14 with the exception of speech-generating devices in the home, 15 there have been few clinical tests of the efficacy of digital tools as an intervention to improve core symptomatic deficits in children with ASD.
13,14
To our knowledge, this is the first randomized clinical trial with an intention-to-treat (ITT) analysis designed to test the efficacy of a wearable machine learning tool for intervention on a core ASD deficit in the natural home environment.
Methods

Study Design
Participants were randomized via a computer script in a 1:1 ratio after all intake measures were completed into either the SG intervention or a treatment as usual control group (both groups received ABA therapy at home at least twice per week) for 6 weeks. A clinical coordinator assigned the participants to their condition. Another clinical coordinator who was blinded to the assignment of participants recorded all primary and secondary outcome measures (see below) at the start of condition (intake), end of 6-week condition (posttest 1), and after 6-week follow-up (posttest 2). The baseline measures Social Communication Questionnaire and abbreviated IQ were collected only at intake. We included a crossover option for the control arm participants, where their posttest 1 appointment served as the start of their treatment period. The study protocol is provided in Supplement 1, and more details are provided in eMethods 1 in Supplement 2.
Eligibility and Screening
Families were recruited between June 2016 and December 2017 and enrolled if they were within driving distance of Stanford University, had a child with ASD between age 6 and 12 years currently receiving ABA therapy at least twice per week at home, scored greater than 15 on the Social Communication Questionnaire, 16 and consented to participate. Parents provided written informed consent at their intake appointment. We did not use IQ for eligibility. The study was conducted in accordance with Stanford University's institutional review board.
Intervention
The SG intervention is worn by the child with ASD at home. The system tracks faces, classifies the emotions of the child's social partners, 10-12,17-19 and provides 2 forms of cues to the child in real time. First, a green indicator box illuminates the smart glasses unit's peripheral monitor when a face is detected within the outward-facing camera's field of view. Second, an emoticon appears in the display and a robotic voice audio cue is played through the bone-conducting speaker of the glasses when a face is classified as expressing 1 of 8 emotions by the machine-learning model: happy, sad, angry, scared, surprised, disgust, "meh," and neutral ( Figure 1 ). Families can opt to disable audio feedback. The system operates at a frame rate of approximately 15 to 20 frames per second, so facial expressions are typically recognized within 100 milliseconds.
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Key Points
Question Can a wearable artificial intelligence intervention designed for use in the home to reinforce facial engagement and emotion recognition improve socialization in children with autism spectrum disorder?
Findings In this randomized clinical trial of 71 children with autism spectrum disorder, children treated at home with the wearable intervention showed a significant improvement in socialization over children only receiving standard of care behavioral therapy.
Meaning
The mobile intervention, which teaches the recognition and relevance of emotion in the child's natural setting, can augment standard of care therapy to achieve higher socialization in children with autism spectrum disorder. We designed the mobile app to be the control center that allows the child's caregiver to manage the system. The app receives images, runs the emotion classifier, and saves video and usage data. We provided 3 engagement activity modes: (1) capture the smile, during which the child is prompted by audio to find an emotion in a family member's face by, for example, telling a joke to elicit the happy emotion; (2) guess the emotion, during which the caregiver asks the child to guess the emotions they are acting and controls the response manually; and (3) free play, an unstructured activity during which the child receives emotional cues for all individuals interacting with them. We automatically logged the activities chosen and compiled the videos of each session for families to review, upload, or delete.
Those in the SG group were asked to use each of the 3 engagement activities at least once and to use the device at home for 20 minutes 3 times per week with family members and once per week with their ABA behavior interventionist (BI), for a total of 4 times per week. Because we gave families the option to delete videos for privacy reasons, we measured usage through the number of days on which at least 1 video was created, whether saved or deleted, during the intervention period. This was an open-label trial; families and their BI were unblinded to the treatment. The clinical coordinator remained blinded for the entire study.
Primary Outcome Measures (Unordered)
The SRS-II 20 total score is a 65-item survey completed by a child's caregiver to identify the presence and severity of so- The child wears smart glasses (A), which are wirelessly synced to an Android smartphone application (B), which runs the machine learning classifiers for face tracking and emotion detection, enables game choice, launches the games, and records the videos for later parent review. The outward facing camera of the glasses captures facial image data that are transmitted to the smartphone for immediate classification. A green box appears in the peripheral monitor of the glass units when a face is detected. In addition, an emoji corresponding to 1 of 8 emotions appears in the monitor when an emotion is detected. Both can appear at the same time, as demonstrated in C. The Superpower Glass intervention primarily consists of these 2 components, with the first encouraging facial awareness and the second teaching correct labeling of the emotion exhibited by the child's social partner. The display allows colors and emoticons to be seen by the child within their peripheral field of view and does not require direct gaze. The form factor therefore rarely averts attention. 
Analysis Sets
We performed analysis on 4 sets of participants. The primary ITT analysis was performed on what is henceforth referred to as the ITT cohort, including all participants who were randomized into the study. We performed secondary analyses on the completers cohort, which included treatment and control participants who completed all intake and posttest 1 measures; the treatment-first cohort, which included all participants assigned to treatment (ITT); and the full-treatment cohort, which included all participants who received the intervention and completed at least their first posttest appointment after the intervention, including crossover participants (eMethods 2 in Supplement 2).
Primary Analysis
To test the efficacy of SG plus ABA vs ABA alone, we used a generalized linear mixed-effects regression model and assessed each outcome separately. The model included all available measurements for all participants randomized in the study, including withdrawn participants and those who did not adhere to the intervention. Specifically, for each outcome measure M in the measures section above, and individual i at time of measure t, we applied the following model: M it =γ 0 +γ 0i +γ 1 weeks it +γ 2 treatment i +γ 3 weeks it × treatment i +ε it , where the individual-specific random effect, γ 0i , was included to account for correlation across repeated measurements within an individual over time, weeks it represents the number of weeks elapsed since randomization for the ith individual at the tth time point, and treatment i is an indicator representing whether the ith individual belongs to the treatment-first group. To test for significance, we use a 2-sided Wald test on γ 3 (representing the impact of treatment over time) at the Bonferroniadjusted level of .0125 to account for the testing of our 4 primary outcomes. We excluded 3 participants from the ITT cohort owing to a randomization error at the intake appointment; testing was performed to ensure that their removal does not affect significance in any of the primary analyses. We further assessed whether abbreviated IQ, age, or sex were modifiers of treatment in the regression analysis. For this purpose, we augmented the above analysis to include the modifier (eg, age) and interaction terms with treatment, week, as well as a 3-way interaction term with treatment and week. Likelihood ratio tests then assessed whether the modifier significantly impacted the treatment effect. In addition to the primary ITT cohort, we applied the same mixed-effects model analysis to the completers cohort to evaluate the impact of the intervention on outcomes among those who completed the study.
Six-Week Follow-up Analysis
To test if a return to baseline occurred in the treatment group, we applied a model that tracks gains from intake to posttest 1 and posttest 2 only among those assigned to the treatment group: M it =γ 0 +γ 0i +γ 1 weeks it × [posttest 1] it +γ 2 weeks it × [posttest 2] it +ε it , where a Wald test on γ 2 allowedusto test whether gains at 12 weeks were (still) significantly different from the intake baseline. The sign and magnitude of the coefficient indicates the point value of the change. We also performed a follow-up analysis on the entire treatment cohort, including control participants who crossed over (eMethods 2 in Supplement 2).
Secondary Measures
We applied the ITT model from the primary analysis to the secondary measures, Child Behavior Checklist and the full VABS-II scale. We also performed the same moderator analysis on the secondary outcome measures.
Treatment Cohort Analysis
We performed further exploratory analyses on the treatmentfirst cohort and then on the full treatment cohort, which included the crossover group. Using mixed-effects linear regression methods, we compared changes in outcome measures to baseline values of abbreviated IQ, age, usage, and the level of BI involvement to evaluate additional trends, such as increased effect of SG use on particular age groups and developmental levels.
Results
A total of 474 families were screened for eligibility. Seventyfour were initially enrolled, but 3 were later excluded owing to a randomization error that occurred early in the study (their data do not affect significance in any of the primary analyses). Of the 71 enrolled participants remaining, 40 (56.3%) were randomly assigned to treatment, and 31 (43.7%) were randomly assigned to control. One participant reported an adverse reaction to the glasses. Participants received between 15 to 20 hours of standard ABA per week. The consort flow diagram of the study participants is in Figure 2 . Participant demographics are reported in Table 1 .
The mean (SD) treatment time between intake and posttest 1 was 6.81 (1.85) weeks. Families in the treatment group used the device on a mean (SD) of 12.12 (5.80) times through the 6-week treatment period, 51% of the requested dosage of 24 days. Participants played guess the emotion and capture the smile in 39.8% and 23.8% of the sessions, respectively, suggesting a potential preference for structured games over the unstructured free play option, which was chosen 36.4% of the time. Families ran a mean (SD) of 3.9 (3.38) sessions with their ABA BI, 65% of the recommended dose. Families did not report problems with the emotion classification, and our empirical measurement of accuracy (eMethods 1 in Supplement 2) was 72%.
Primary Analysis
Results from the primary ITT analysis of 71 individuals and the completers cohort of 52 individuals are presented in Table 2 . Composition of the cohorts is presented in eTable 1 in Supple- ment 2. The VABS-II socialization subscale score significantly increased between start and end of the intervention in treatment-to-control comparisons (mean treatment impact: 4.58 points, P = .005, mean learning effect: −1.56 points in the ITT cohort; mean treatment impact: 5.38 points, P < .001, mean learning effect: −1.58 points in the completers cohort). Emotion Guessing Game, NEPSY-II-Affect, and SRS-II showed larger positive mean changes in treatment participants compared with controls, but those improvements were not significant ( Table 2) . Moderator analyses for abbreviated IQ, age, and sex showed a moderation effect for sex for the EGG, with girls showing greater improvement (likelihood ratio test P = .004; eTable 2 in Supplement 2).
Six-Week Follow-up Analysis
Results from the follow-up analysis conducted on the treatment-first group for all ITT participants (n = 40) and completers (n = 27) are presented in Table 3 . We observed a reduced mean improvement from intake to follow-up on the 
Secondary Measures
No significant changes from intake to posttest 1 were observed on secondary measures (eTable 4 in Supplement 2). The VABS-II adaptive composite score showed a moderation effect for age, with younger participants showing slightly greater improvement (likelihood ratio test P = .04, eTable 2 in Supplement 2).
Treatment Cohort Exploratory Analysis
We observed no noteworthy exploratory interactions beyond the ITT moderator. Specifically, we found no significant correlation between increased BI involvement in therapy and social skills gains. Usage in the entire treatment completer cohort, including 12 additional crossover participants, was similar to the treatment-first cohort (eResults in Supplement 2).
Discussion
An ITT analysis revealed that children with ASD receiving ABA who were randomized into the SG intervention showed significant improvements between intake and conclusion on the VABS-II socialization subscale, a clinical measure sensitive to changes in socialization. [22] [23] [24] [25] These gains were similar to those exhibited in other studies. 24,25 Significant differences between cohorts were not observed on the other primary end points. While there was a positive change on VABS-II socialization between intake and 6 weeks after the conclusion of the SG treatment, this was not significant. Additional gains at posttest 2 were observed for SRS-II and EGG, but given a lack of posttest 2 control data, we cannot rule out a practice effect a Statistically significant with Bonferroni correction at P < .0125.
Research Original Investigation
esis that the SG intervention can improve social skills of children with ASD between the ages of 6 and 12 years as an augmentation to standard of care therapy. On average, participants used the device on half as many days as initially recommended. Potential reasons for this include decreased motivation by parents to use the device over time and/or decreased engagement from children with the device over time. These factors should be examined in future studies by improving system engagement and further examining the impact of the intervention.
The SG intervention has at least 2 potential mechanisms of action: reinforcement that faces have variation in emotion (salience of emotion) and training on how to differentiate emotions. Analyses of potential correlations between outcome measures and usage or participant demographics yielded no clear conclusions about best responders. Nevertheless, we hypothesize that the dual mechanisms of action may have contributed to the observed socialization gains despite use in fewer sessions than the prescribed usage. Beyond these 2, it is possible that the learning aid generally encourages social interaction in the family around face contact and emotion, thereby increasing social acuity in the child.
Limitations
While our change was in line with previous reports using the VABS-II, the poststudy empirical variance suggested that the study may be underpowered by a factor of 2. Further limitations include low participant adherence to the recommended treatment dosing and the restricted recruitment of individuals to within driving distance of Stanford where the population may be enriched for familiarity with technology. Additionally, owing to the inherent demographic and behavioral heterogeneity of children with ASD and differing amounts of ABA therapy received prior to the intervention, children began the intervention with varying levels of social skills. Finally, because control participants did not have a second posttest appointment before crossing over into treatment, we were unable to perform direct comparison tests for sustained gains. While data from the treatment group points toward a need to increase the 6-week treatment period, further research is required.
Conclusions
This is the first randomized clinical trial to demonstrate efficacy of a wearable behavioral intervention for children with ASD, to our knowledge. The intervention teaches children emotion recognition, facial engagement, and the salience of emotion, suggesting the potential for multiple mechanism(s) of action driving the observed improvement in social behavior. Results of this study underscore the potential of digital home therapy to augment the current standard of care. Open Access: This article is published under the JN-OA license and is free to read on the day of publication.
Author Contributions: Mr Voss and Dr Wall had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. The purpose of this research is to study the effects of a novel combined software-hardware device built onto commercially available Google Glass technology that provides an automated emotion expression recognition system and face tracker to determine the effects of providing social cues to individuals with a diagnosis of ASD. This novel device will use a camera, microphone, and head motion tracker that will record the behavior of the subject during interactions with other people. The system is designed to give participants non-interruptive social cues in real-time and will record social responses that can later be used to help aid behavioral therapy.
b)
State what the Investigator(s) hope to learn from the study. Include an assessment of the importance of this new knowledge. Investigators hope to learn the effects of this novel software-hardware device in terms of providing social cues to individuals with ASD. Refining and evaluating this system has implications to not only help aid behavioral interventions with individuals with ASD, but it also has broader implications on new forms of human-computer and human-human interaction. The system's ability to provide continuous behavioral therapy outside of clinical settings will enable dramatically faster gains in social acuity that may, within a limited and self-directed period of time, encourage the child to engage in more advanced social settings on his/her own.
c)
Explain why human subjects must be used for this project. (i.e. purpose of study is to test efficacy of investigational device in individuals with specific condition; purpose of study is to examine specific behavioral traits in humans in classroom or other environment) Human subjects must be used for this project because the purpose of the study is to determine the efficacy of this novel device in social interactions for individuals with ASD. There are no suitable animal models for facial emotion recognition in ASD, nor are there comparable behavioral therapies for animals, and therefore, human subjects must be used. Participants: Participants will be at least 6 years old. We anticipate recruiting up to 80 ASD participants. We will also be recruiting family members and friends of participants to consent to participate as "non-participants." The research staff will obtain informed consent before any study procedures begin. Consent and assent will be obtained either electronically or in-person.
Recruitment and Screening:
We will utilize crowd-sourced recruitment by advertising our study on Facebook, parent groups, and listservs, as well as partner with our collaborators. We will partner with Autism Comprehensive Educational Services (ACES) who offer a variety of behavioral and educational services for individuals impacted with autism or other developmental disabilities in the home, school, community, and at accredited sites throughout the United States. Our main contact will be Heather O'Shea, Ph.D., BCBA-D, Chief Clinical Officer, and she will manage the staff from ACES. ACES will help with participant selection: ACES will help recruit some of our participants. ACES will define and assist in the screening process for eligible participants from said population. They will screen for participants based off of recruitment criteria explained in IRB 34059. Upon selection of participants, ACES will provide contact information to Autism Glass, Wall Lab for which Autism Glass, Wall Lab will officially enroll selected participants.
During recruitment participants will be able to access a RedCap survey from the recruitment website and through other recruitment efforts (i.e. ACES). We will ask interested participants to fill out the Screening Questionnaire. Our goal will be to determine eligibility based on location (needs to be local to Stanford), still interested in participating, has a child that meets our eligibility criteria, and a brief overview of the child. We will also ask these families to provide a short home video of the potential participant. We will ask families to submit a 3-5 minute home video that clearly shows the child's face and hands, as well as includes a "play time" or "conversational" social interaction. We will use this video to get a first pass understanding of the phenotype of the child as well as compare this first video to a 3-5 minute home video of the child at the end of the study to track any behavioral changes in social interactions. The conclusion video will have the same requirements as this first video and will be analyzed in the same way. Families will send home videos to study coordinators via MedSecureSend and video data are stored on Stanford Medicine Box. Study coordinators will send an email to families with the link to use this secure platform. Video data will be reviewed by the Wall Lab. Participants with ASD will then be asked to provide a copy of their diagnosis report when they come in for the in lab assessments. Dr. Feinstein will make judgment on eligibility and other technical questions in diagnosis if needed.
We will end recruitment once we meet our targeted enrollment goal.
Intervention Procedures:
First session (Onboarding): Subjects and family members will be asked to come to the Wall Lab at 1265 Welch Rd or 1110 Burnett Ave to obtain written or electronic consent. Individuals will meet the study team, will discuss expectations with study manager, and go over scheduling. Baseline cognitive testing will be conducted in a private assessment by a blinded 2. Study Procedures ! research coordinator, where participants will complete the ABIQ. Following intake measures, an independent staff member not involved in the data collection process will randomize the participant. Following randomization, if participants were assigned to the experimental group, they will meet the independent staff member to be instructed on Glass usage. The child/family will then take the Glass home for the duration of the study or we will mail the units home.
Intervention Delivery:
Participants randomized to the treatment condition will use the Google Glass system for 6 weeks following onboarding, where they will be asked to use the glasses 3-4x/week for at least 20 minutes each session with either parents or ABA therapist. Participants will have phone calls with study managers to see how usage of the device at home is going throughout the 6 weeks.
Participants randomized to the control condition will not receive any intervention for 6 weeks following onboarding appointment.
Follow-Up:
6 week post-test: Treatment and Control participants will return to Stanford to complete outcome measures 6 weeks following initial onboarding appointment.
After the 6-week post-test appointment, control participants will be able to cross-over to treatment condition and will receive Google Glass device to use for 6 weeks. Treatment participants will return their google glass device. Both groups will schedule their final follow-up appointment for week 12 where they will complete outcome measures.
Conclusion:
At week 12, treatment participants will return to Stanford to complete outcome measures. Cross-over Control participants will return the google glass device and complete outcome measures. At the end of the 12-week period and after completion of the final follow up assessment, a $50 Amazon gift card is provided as compensation for participation in the study. Child Assessments (conducted by blinded research coordinator at Onboarding, Followup, Conclusion): Participants will also undergo the Abbreviated Battery IQ (ABIQ), which consists of two subsections of the Stanford-Binet, 5th Edition Intelligence Test. We will also collect the NEPSY-II Affect Recognition and Emotion Guessing Game, as well as Overall Social Interaction (Brief Observation of Social Communication Change, BOSCC). At one of the inperson appointments, we will have participants and consented/assented family members read aloud a script (see section 16) into a microphone to collect audio data to later analyze to help with expression recognition software.
Third, we focused the empirical assessment of emotion classification accuracy on Guess the Emotion game play sessions in which the parent selects an emotion to start a session, acts the emotion shortly after making the selection and then records the child's guess, whether correct or incorrect. We sampled between two different emotion prompts, prompt A (e.g. "happy") and prompt B (e.g. "sad") selected in turn by the parent. We considered a true positive found an emotion classification prediction of prompt A before prompt B was selected, we called this a positive. With this procedure, we achieved an overall accuracy of 0.72. Although lower than the that seen with the Cohn-Kanade Dataset (which contains manually annotated expressions acted out by adults facing high resolution cameras together with egocentric framing of the head/face), this accuracy is high for active, real use systems like the SG tool. Moreover, due to the heuristic nature of this measurement (due to the computational tractability and reliability of manual measurement of the thousands of images generated per family during use), this value is likely to be an underestimate.
In accord with this accuracy assessment, families did not report problems with the emotion classification accuracy during the study.
eMethods 2. Treatment Crossover Analysis
Treatment Crossover Analysis
To take advantage of the additional data available for treatment cohorts, we repeated the exploratory treatment cohort analysis with the full treatment cohort including participants who crossed over from the control group. The data was normalized such that the control participants' post-test 1 visit is now labeled as their treatment intake appointment.
Full Treatment Cohort Demographics
We broke the full cohort down by the same analysis groups. None of the group demographics had statistically significant differences. 
Cohort
